The validity of 18F-GE180 as a TSPO imaging agent. (2019)

First Author: Zanotti-Fregonara P
Attributed to:  MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00259-019-4268-4

PubMed Identifier: 30656358

Publication URI: http://europepmc.org/abstract/MED/30656358

Type: Journal Article/Review

Volume: 46

Parent Publication: European journal of nuclear medicine and molecular imaging

Issue: 6

ISSN: 1619-7070